Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 20, Issue 2, pp. 284-295
PubMed
Published By
Print ISSN
Online ISSN
History
- Received July 20, 2020
- Revision received September 24, 2020
- Accepted November 18, 2020
- Published first December 9, 2020.
Article Versions
- Previous version (December 9, 2020 - 07:06).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Luping Huang1,#,
- Denian Wang2,#,
- Zhongxue Feng1,#,
- Huan Zhao1,#,
- Fei Xiao3,#,
- Yong'gang Wei4,#,
- Heng Zhang5,
- Hongyu Li6,#,
- Lingmiao Kong1,
- Min Li1,
- Fei Liu4,
- Haili Zhang4, and
- Wei Zhang1,*
- 1Department of Critical Care Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan, China.
- 2Department of Respiratory and Critical Care Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Sichuan, China.
- 3Department of Intensive Care Unit of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Sichuan, China.
- 4Department of Liver Surgery, West China Hospital, Sichuan University, Sichuan, China.
- 5Department of Neurosurgery, West China Hospital, Sichuan University, Sichuan, China.
- 6Liver Transplantation Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
- ↵*Corresponding Author:
Wei Zhang, Department of Critical Care Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, No. 1, Ke Yuan 4th Road, Chengdu 610041, China. Phone: 86-28-85164092; Fax: 86-28-85164092; E-mail: zhangwei197610{at}163.com
↵#L. Huang, D. Wang, Z. Feng, H. Zhao, F. Xiao, Y. Wei, and H. Li contributed equally to this article.
February 2021
Volume 20, Issue 2
Volume 20, Issue 2
Inhibition of Intermedin (Adrenomedullin 2) Suppresses the Growth of Glioblastoma and Increases the Antitumor Activity of Temozolomide
Jump to section
Advertisement